Answers are grounded in this paper and cite their sources.
Sarcopenia independently predicts poor survival outcomes in patients with R/M HNC undergoing ICI therapy, whereas conventional inflammatory markers such as NLR, PLR, and LMR, alone or in combination with sarcopenia, lack independent prognostic value. Routine pre-treatment evaluation of skeletal muscle mass using CT imaging may offer a practical and effective tool for patient risk stratification.
No takes yet. Share an insight, caveat, or question.
Kasahara et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: